<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-MAR-C-MOH</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Accelerating the Response to HIV/AIDS and Tuberculosis in Morocco by 2023</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Morocco - TB/HIV - Ministry of Health of the Kingdom of Morocco - MOH.  This program has the following goals: En 2023 les nouvelles infections sont r&#xE9;duites de 50% par rapport &#xE0; 2018. // By 2023, new infections are reduced by 50% when compared to 2018..  En 2023,  la mortalit&#xE9; li&#xE9;e au VIH est r&#xE9;duite de 50% par rapport &#xE0; 2018. // By 2023, HIV-related mortality is reduced by 50% when compared to 2018..  La discrimination est r&#xE9;duite et l&apos;acc&#xE9;s des PVVIH &#xE0; l&apos;appui psychosocial est renforc&#xE9;. // Discrimination is reduced and access to psychosocial support for PLWHIV is increased..  La gouvernance est renforc&#xE9;e au niveau national, r&#xE9;gional et local pour assurer l&#x2019;acc&#xE9;l&#xE9;ration et la durabilit&#xE9; de la riposte. // Governance is strengthened at national, regional and local levels to ensure an accelerated and sustainable response..  R&#xE9;duire le nombre de d&#xE9;c&#xE8;s li&#xE9;s &#xE0; la tuberculose de 60% en 2023 par rapport &#xE0; l&apos;ann&#xE9;e 2015. // By 2023, the number of TB-related deaths is reduced by 60% when compared to 2015.. The objectives of this program are: 1.1 En 2023, 90% des populations cl&#xE9;s et vuln&#xE9;rables (PS, HSH, PID, d&#xE9;tenus, migrants) utilisent le paquet des services de pr&#xE9;vention combin&#xE9;e selon les approches diff&#xE9;renci&#xE9;es. // 1.1 By 2023, 90% of key and vulnerable populations (SW, MSM, PWID, prisoners, migrants) are using the package of combined prevention services according to differentiated approaches..  1.3 En 2023, l&apos;&#xE9;limination de la transmission du VIH de la m&#xE9;re &#xE0; l&apos;enfant et de la syphillis cong&#xE9;nitale aura &#xE9;t&#xE9; certifi&#xE9;e pour le Maroc. // 1.3 By 2023, the elimination of mother-to-child transmission of HIV and congenital syphilis will have been certified for Morocco..  2.1 En 2023, 90% des PVVIH y compris les populations cl&#xE9;s, connaissent leur statut s&#xE9;rologique pour le VIH. // 2.1 By 2023, 90% of PLWHIV including key populations, know their HIV status..  2.3 En 2023, 90% des PVVIH y compris les populations cl&#xE9;s b&#xE9;n&#xE9;ficiant d&apos;un traitement ARV ont une charge virale ind&#xE9;tectable &#xE0; 12 mois. // 2.3 By 2023, 90% of PLWHIV, including key populations receiving ARV treatment, have an undetectable viral load at 12 months..  3.1 L&apos;environnement social et juridique prot&#xE9;ge les PVVIH et les populations vuln&#xE9;rables contre la discrimination. // 3.1 The social and legal environment protects PLWHIV and vulnerable populations from discrimination..  4.1 La coordination et le leadership de la riposte nationale au sida et &#xE0; la TB sont efficacement assur&#xE9;s au niveau central et d&#xE9;centralis&#xE9;. // 4.1 Coordination and leadership of the national AIDS and Tuberculosis response is effectively provided at central and decentralized levels..  4.4 Les informations strat&#xE9;giques de qualit&#xE9; sur les IST, le VIH sont produites et utilis&#xE9;es pour la prise de d&#xE9;cision. // 4.4 Quality strategic information on STIs, HIV is produced and used for decision-making..  3.3 D&apos;ici 2023, 80% des PVVIH suivies b&#xE9;n&#xE9;ficient du paquet de services d&apos;appui psychologique, social et juridique. // 3.3 By 2023, 80% of PLWHIV in care benefit from the package of psychological, social and legal support services..  1.Augmenter le nombre d&#x2019;&#xE9;pisodes de tuberculose d&#xE9;tect&#xE9;s &#xE0; au moins 34.000 &#xE0; l&#x2019;horizon 2023 et maintenir le taux de succ&#xE8;s th&#xE9;rapeutique &#xE0; au moins 90%. // 1. To increase the number of tuberculosis episodes detected to at least 34,000 by 2023 and to maintain the treatment success rate at least 90%..  2. Augmenter le nombre de cas de tuberculose multi-r&#xE9;sistante mis sous traitement &#xE0; 450 et leur taux de succ&#xE8;s th&#xE9;rapeutique &#xE0; au moins 80% &#xE0; l&#x2019;horizon 2023. // 2. To increase the number of cases of multidrug-resistant tuberculosis under treatment to 450 and their treatment success rate to at least 80% by 2023..  3. Assurer le d&#xE9;pistage syst&#xE9;matique de l&#x2019;infection VIH chez 95% des malades tuberculeux notifi&#xE9;s &#xE0; l&#x2019;horizon 2023 et maintenir &#xE0; 100% la proportion cas notifi&#xE9;s de tuberculose/VIH mis sous traitement par les m&#xE9;dicaments antir&#xE9;troviraux. // 3. Ensure systematic testing for HIV infection in 95% of tuberculosis patients notified by 2023 and maintain at 100% the proportion of notified cases of tuberculosis/HIV treated with antiretroviral drugs.  4. Assurer un traitement pr&#xE9;ventif contre la tuberculose chez au moins 45.000 personnes &#xE0; risque durant les 3 ann&#xE9;es couvertes par le PSN. // 4. Provide preventive treatment against tuberculosis for at least 45,000 people at risk during the 3 years covered by the NSP.</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Morocco</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Morocco</narrative>
  </participating-org>
  <participating-org role="3" type="10">
   <narrative xml:lang="EN">Ministry of Health of the Kingdom of Morocco</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">Ministry of Health of the Kingdom of Morocco</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="MAR-C-MOH" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="b7c8ad3a-ac35-4b5c-b199-2fc1bb40164f" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-08-24" type="1"></activity-date>
  <activity-date iso-date="2020-08-24" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Emina RYE-FLORENTZ</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>emina.rye-florentz@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Emina RYE-FLORENTZ</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>emina.rye-florentz@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="MA" percentage="100">
   <narrative xml:lang="EN">Morocco</narrative>
  </recipient-country>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">TB/HIV</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="4.17" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="10.12" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="10.29" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="5.9" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="D8A4C47C-BD32-4DDC-98CD-FDAE0FD2B520" percentage="6.15" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Pharmaceutical Products (HPPP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="33.18" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="4.22" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="2.48" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="4.6" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="1.47" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="1.46" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="15.94" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1253765</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">2050217</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">1655756</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1727257</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">2412529</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">6600353</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">873225</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1212459</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1217658</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">1416203</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">857846</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">918822</value>
  </budget>
  <capital-spend percentage="10.29"></capital-spend>
  <transaction ref="3101d651-f12e-4121-ae59-d1e2f981b70a">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-19"></transaction-date>
   <value currency="USD" value-date="2021-01-19">11787008.37</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MAR-C-MOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Ministry of Health of the Kingdom of Morocco</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3aff7e73-99e7-4ac1-aa0c-0f0db1ca33f6">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-28"></transaction-date>
   <value currency="USD" value-date="2021-01-28">3268715.22</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MAR-C-MOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Ministry of Health of the Kingdom of Morocco</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="41d7e401-19fd-4499-91aa-f557dd9d8e0d">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-21"></transaction-date>
   <value currency="USD" value-date="2021-05-21">246702.55</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MAR-C-MOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Ministry of Health of the Kingdom of Morocco</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="2ebc00cc-116c-49e4-9299-3cfe15d56bd1">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-21"></transaction-date>
   <value currency="USD" value-date="2021-05-21">94707.42</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MAR-C-MOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Ministry of Health of the Kingdom of Morocco</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9ac7ef8b-ab7c-405d-a79f-ce63ace68620">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-17"></transaction-date>
   <value currency="USD" value-date="2021-06-17">339134</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MAR-C-MOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Ministry of Health of the Kingdom of Morocco</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="be55a5a5-84b5-4d81-bc35-b499579a47e1">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-24"></transaction-date>
   <value currency="USD" value-date="2021-06-24">9297.2</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MAR-C-MOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Ministry of Health of the Kingdom of Morocco</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for MAR-C-MOH</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 10606 Denominator: 42000 Percentage: 25.25</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 15049 Denominator: 21500 Percentage: 70.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 182 Denominator: 200 Percentage: 91.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 19213 Denominator: 72000 Percentage: 26.68</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 236</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 236</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 27642 Denominator: 42000 Percentage: 65.81</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 30754</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 328 Denominator: 1200 Percentage: 27.33</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 47854 Denominator: 72000 Percentage: 66.46</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 925 Denominator: 1200 Percentage: 77.08</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 40.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Percentage: 46.60</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 88.50</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 96.00</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for MAR-C-MOH</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 8</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 6.2</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 4.6</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 3</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of sex workers who are living with HIV</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 1.70</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 2.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of men who have sex with men who are living with HIV</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Percentage: 4.50</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.50</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs who are living with HIV</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Percentage: 7.10</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 7.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for MAR-C-MOH</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 86</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 91</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 91</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 93</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Percentage: 46.60</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 60.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 70.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of sex workers reporting the use of a condom with their most recent client</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 63.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 65.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Notification of RR-TB and/or MDR-TB cases &#x2013; Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 63.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 88.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 91.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 92.33</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
